Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Sean Liu, Hung-Mo Lin, Ian Baine, et al.
Nature Medicine (2020) Vol. 26, Iss. 11, pp. 1708-1713
Open Access | Times Cited: 469

Showing 1-25 of 469 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1438
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg, Fatima Amanat, Adolfo Firpo, et al.
Science (2020) Vol. 370, Iss. 6521, pp. 1227-1230
Open Access | Times Cited: 1186
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Romina Libster, Gonzalo Pérez Marc, Diego Wappner, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 7, pp. 610-618
Open Access | Times Cited: 858
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 1015-1027
Open Access | Times Cited: 513
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 6141-6150
Open Access | Times Cited: 444
The first 12 months of COVID-19: a timeline of immunological insights
Thiago de Amorim Carvalho, Florian Krammer, Akiko Iwasaki
Nature reviews. Immunology (2021) Vol. 21, Iss. 4, pp. 245-256
Open Access | Times Cited: 423
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Giacomo Lanzoni, Elina Linetsky, Diego Correa, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 5, pp. 660-673
Open Access | Times Cited: 338
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
Emerging treatment strategies for COVID-19 infection
Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Eleni Korompoki, et al.
Clinical and Experimental Medicine (2020) Vol. 21, Iss. 2, pp. 167-179
Open Access | Times Cited: 316
COVID-19: breaking down a global health crisis
Saad I. Mallah, Omar Ghorab, Sabrina Al-Salmi, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 305
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3452-3466.e18
Open Access | Times Cited: 258
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Ioannis P. Trougakos, Κimon Stamatelopoulos, Evangelos Terpos, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 240
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
Eric Salazar, Paul Christensen, Edward A. Graviss, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 11, pp. 2290-2303
Open Access | Times Cited: 236
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
David J. Sullivan, Kelly A. Gebo, Shmuel Shoham, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1700-1711
Open Access | Times Cited: 234
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan, M. Narwal, Sydney A. Majowicz, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 173
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
Max R. O’Donnell, Beatriz Grinsztejn, Matthew J. Cummings, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 160
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Eric Salazar, Paul Christensen, Edward A. Graviss, et al.
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 90-107
Open Access | Times Cited: 151
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 148
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
Stephen A. Klassen, Jonathon W. Senefeld, Patrick W. Johnson, et al.
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 5, pp. 1262-1275
Open Access | Times Cited: 148
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
Xinyi Xia, Kening Li, Lingxiang Wu, et al.
Blood (2020) Vol. 136, Iss. 6, pp. 755-759
Open Access | Times Cited: 145
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
Yuanling Yu, Meiyu Wang, Xiao‐Ai Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 101
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
Enzyme-Linked Immunosorbent Assay: Types and Applications
Hovhannes Hayrapetyan, Thao Tran, Eglis Tellez‐Corrales, et al.
Methods in molecular biology (2023), pp. 1-17
Closed Access | Times Cited: 70
Page 1 - Next Page

Scroll to top